Physician training is never a failure

American Journal on Addictions

Volumn 18, Issue 4, 2009, Pages 337-338

  Gordon, Adam J ^a,b   Liberto, Joseph ^a,c   Granda, Stephanie ^d   Salmon Cox, Sara ^a   Andree, Tykia ^a   McNicholas, Laura ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d SAINT LOUIS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; OPIATE;

AMBULATORY CARE; CERTIFICATION; DRUG EFFICACY; EDUCATION PROGRAM; FOLLOW UP; GOVERNMENT; HEALTH CARE; HUMAN; LAW; LETTER; MEDICAL EDUCATION; MEDICAL INFORMATION; MENTAL HEALTH SERVICE; METHADONE TREATMENT; OPIATE ADDICTION;

EID: 67651244239     PISSN: 10550496     EISSN: 15210391     Source Type: Journal    
DOI: 10.1080/10550490902931373     Document Type: Letter

References (16)

1. Gordon AJ, Liberto J, Granda S, et al. Outcomes of DATA 2000 certification trainings for the provision of buprenorphine treatment in the Veterans Health Administration. Am J Addict. 2008;17:459-462.
2. O'Connor PG, Fiellin DA. Pharmacologic treatment of heroin-dependent patients. Ann Intern Med. 2000;133:40-54.
3. Fiellin DA, Rosenheck RA, Kosten TR. Office-based treatment for opioid dependence: reaching new patient populations. Am J Psychiatry. 2001;158:1200-1204.
4. Fiellin DA, O'Connor PG. Office-based treatment of opioid dependent patients. N Engl J Med. 2002;347:339-345.
5. Institute of Medicine. Improving the quality of healthcare for mental and substance-use conditions: The quality chasm series. Washington, D.C.: The National Academies Press, 2005.
6. Gordon AJ, Sullivan LE, Alford DP, et al. Update in addiction medicine for the generalist. J Gen Intern Med. 2007;22:1190-1194.
7. Gordon AJ, Fiellin DA, Friedmann PD, et al. Update in addiction medicine for the primary care clinician. J Gen Intern Med. 2008;23:2112-2116.
8. Rogers EM. Diffusion of innovations. 5th ed. New York: Free Press, 2003.
9. Walley AY, Alperen JK, Cheng DM, et al. Office-based management of opioid dependence with buprenorphine: clinical practices and barriers. J Gen Intern Med. 2008;23:1393-1398.
10. Fiellin DA, Pantalon MV, Chawarski MC, et al. Counseling plus buprenorphine-naloxone maintenance therapy for opioid dependence. N Engl J Med. 2006;355:365-374.
11. Fudala PJ, Bridge TP, Herbert S, et al. Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone. N Engl J Med. 2003;349:949-958.
12. Stein MD, Cioe P, Friedmann PD. Buprenorphine retention in primary care. J Gen Intern Med. 2005;20:1038-1041.
13. Goodman F, Gordon A, Kivlahan D, et al. Criteria for non-formulary use of buprenophine sublingual tablets for opioid dependence, criteria for use monograph. Available at: http://www.pbm.va.gov/archive/ Buprenorphine.pdf. Accessed January 26, 2009.
14. Goodman F, Gordon A, Kivlahan D, et al. Criteria for use of buprenophine/naloxone and Buprenorphine sublingual tablets. Available at: http://www.pbm.va.gov/criteria/BuprenorphineCriteriaForUse.pdf. Accessed January 26, 2009.
15. Department of Veterans Affairs VHA. Uniform mental health services in VA medical centers and clinics. Available at: http://www.va.gov/ vhapublications/ViewPublication.asp?pub-ID=1762. Accessed March 23, 2009.
16. Gordon AJ, Trafton JA, Saxon AJ, et al. Implementation of buprenorphine in the Veterans Health Administration: Results of the first 3 years. Drug Alcohol Depend. 2007;90:292-296.